Guangjian Liu
- Hepatology top 0.5%
- Epidemiology top 5%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (42 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers)Liver Disease Diagnosis and Treatment (15 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Guangjian Liu
117 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 135
- Hepatology 1.2k
- Epidemiology 882
- Surgery 695
- Pulmonary and Respiratory Medicine 605
- Radiology, Nuclear Medicine and Imaging 583
Countries citing papers authored by Guangjian Liu
This map shows the geographic impact of Guangjian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangjian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangjian Liu more than expected).
Fields of papers citing papers by Guangjian Liu
This network shows the impact of papers produced by Guangjian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangjian Liu. The network helps show where Guangjian Liu may publish in the future.
Co-authorship network of co-authors of Guangjian Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Guangjian Liu. A scholar is included among the top collaborators of Guangjian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangjian Liu. Guangjian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 23 | |
| 4 | 4 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 25 | |
| 11 | 94 | |
| 12 | 32 | |
| 13 | 9 | |
| 14 | 11 | |
| 15 | 8 | |
| 16 | 5 | |
| 17 | 13 | |
| 18 | Protection Effect of Endothelin Receptor Antagonist on Blood Vessel in Patients with Subarachnoid Hemorrhage | 1 |
| 19 | 1 | |
| 20 | 124 |
About Guangjian Liu
Guangjian Liu is a scholar working on Hepatology, Health Informatics and Radiology, Nuclear Medicine and Imaging, having authored 118 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Liver Disease Diagnosis and Treatment (15 papers). The work is most often cited by research in Hepatology (1.2k citations), Health Informatics (41 citations) and Epidemiology (882 citations). Guangjian Liu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ming‐De Lu, Xiaoyan Xie, Zuo‐Feng Xu, Hui‐Xiong Xu, Jinyu Liang, Li‐Da Chen, Ming Kuang, Manxia Lin, Wei Wang and Yanling Zheng. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.